News MedinCell S.A.

Equities

MEDCL

FR0004065605

Pharmaceuticals

Market Closed - Euronext Paris Other stock markets 11:55:00 2025-12-12 am EST			5-day change	1st Jan Change
27.56 ^EUR	-5.49%		+6.00%	+65.82%

Dec. 10	Medincell Narrows Operating Loss in First Half
Dec. 10	MedinCell Says Partner Filed US FDA Application for Once-monthly Schizophrenia Treatment	MT

Medincell Narrows Operating Loss in First Half	Dec. 10
MedinCell Says Partner Filed US FDA Application for Once-monthly Schizophrenia Treatment	Dec. 10	MT
French and Benelux stocks-Factors to watch	Dec. 10	RE
MedinCell S.A., H1 2026 Earnings Call, Dec 09, 2025	Dec. 09
Medincell H1 revenues EUR 11.6 mln	Dec. 09	RE
Medincell Publishes its Consolidated Half-Year Financial Results	Dec. 09	BU
Medincell Files for FDA Approval of Olanzapine LAI	Dec. 09
Teva Pharmaceuticals Submits FDA Application for Monthly Schizophrenia Treatment	Dec. 09	MT
Medincell’s Partner Teva Pharmaceuticals Announces the New Drug Application1 Submission to U.S. FDA for Olanzapine Extended-Release Injectable Suspension (TEV-'749 / mdc-TJK) for the Once-Monthly Treatment of Schizophrenia in Adults	Dec. 09	BU
MedinCell S.A. Reports Earnings Results for the Half Year Ended September 30, 2025	Dec. 08	CI
Earnings calendar for week of December 8-12, 2025: Oracle, Adobe, Broadcom a trio to watch	Dec. 07
Medincell: Videoconference and Publication of Half-year Financial Results, Tuesday, December 9, 2025	Dec. 01	BU
Medincell Management to Present at the 8th Annual Evercore Healthcare Conference and at the Piper Sandler 37th Annual Healthcare Conference	Nov. 27	BU
Medincell Shares Rise Following $3 Million Grant from Gates Foundation	Nov. 25
Medincell SA receives $3 million grant from Gates Foundation to fight malaria	Nov. 24	RE
Medincell Awarded New Grant to Fight Malaria	Nov. 24	BU
Medincell Management to Participate in Fireside Chat at the Jefferies London Healthcare Conference 2025 (London - Nov. 17-20, 2025)	Nov. 13	BU
Paris Surges Again While Wall Street Hesitates	Nov. 11
CAC40: Europe's Powerhouse Surges 2.6% in 48 Hours, Outperforming the Nasdaq	Nov. 11
CAC 40 Boosted by Luxury Sector and US Market Rebound	Nov. 11
MedinCell Appoints Chief Strategy Officer for US Finance	Nov. 11	MT
Medincell appoints chief strategy officer, US finance	Nov. 11
Medincell Appoints Dr Grace Kim, Chief Strategy Officer, U.S. Finance, to Advance into Next Stage of US Capital Growth	Nov. 11	CI
Medincell Appoints Dr Grace Kim, Chief Strategy Officer, U.S. Finance, to Advance into Next Stage of US Capital Growth	Nov. 11	BU
Medincell Appoints Dr Grace Kim, Chief Strategy Officer, U.S. Finance, to Advance into Next Stage of US Capital Growth	Nov. 11	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News MedinCell S.A.

Equities

MEDCL

FR0004065605

Pharmaceuticals

Filters